British pharmaceuticals firm pays $3bn to end probes

The Guardian

British pharmaceuticals firm pays $3bn to end probes by American authorities into sale and marketing of drugs such as Avandia and Wellbutrin

British drugs giant GlaxoSmithKline has agreed to pay $3bn (£1.9bn) to settle a series of criminal and civil investigations by the US authorities into the sales and marketing of some of its best-known products.

Among the cases the payment will settle are a US justice department probe into the marketing of diabetes drug Avandia, which has been linked to heart attack risks. Avandia was withdrawn from the European market last year and sales were limited in the US.

Read the entire article

Please Share This Article... Thank you :-)

There are no related articles for this article

Translate this page

English Arabic Chinese (Simplified) Dutch French German Italian Japanese Korean Norwegian Portuguese Russian Spanish Swedish

If translation is incomplete,
please refresh the page (F5)

Latest Newsletter

How To Explain Your Illness to Your Teenager

by Kathleen McCue. A teenager facing a parent's illness may go off in all kinds…

Reasons for Failure: Fatal Alibis That Prevent Success

by Napoleon Hill. People who do not succeed have one distinguishing trait in…

Desire: The Starting Point of All Achievement

by Napoleon Hill (original 1937 text). Edwin C. Barnes’ desire was not a hope!…

Saturated Fats: They Are NOT Causing Heart Disease?

by Louisa L. Williams, N.S., D.C., N.D. The much-maligned saturated fats —…

Our Planetary Journey: From Catastrophobia to Spiritual Awakening

by Barbara Hand Clow. Many people are afflicted with catastrophobia — an…

Why & How To Pick A Spiritual Practice

by Sophie Rose. In this age of technology and materialism, when many wonder…

Horoscope Current Week

by Pam Younghans. This weekly astrological journal is based on planetary…